Repurposing of Yunnan Baiyao as an Alternative Therapy for Minor Recurrent Aphthous Stomatitis
Table 3
The number of patients in experimental and placebo groups on day 3 and day 5 based on ulcer size.
Day 3
Day 5
P
P
Experimental group (%)
Placebo group (%)
Experimental group (%)
Placebo group (%)
Number
113
114
113
114
Size (mean ± SD)
3.4 ± 5.3
5.3 ± 6.5
0.01*
2.1 ± 5.6
3.7 ± 6.0
<0.01**
Significant improvement
31 (27.4)
18 (15.8)
0.03***
75 (66.4)
57 (50.0)
0.01****
EIsize = 100%
11 (9.7)
6 (5.3)
39 (34.5)
24 (21.1)
EIsize = 70–100%
20 (17.7)
12 (10.5)
36 (31.9)
33 (28.9)
Nonsignificant improvement
82 (72.6)
96 (84.2)
38 (33.6)
57 (50.0)
EIsize = 30–70%
35 (31.0)
38 (33.3)
16 (14.2)
21 (18.4)
EIsize = 0–30%
47 (41.6)
58 (50.9)
22 (19.5)
36 (31.6)
*and **: P values represent the comparisons of ulcer size between groups on days 3 and 5, respectively.
***and ****: P values represent the comparisons of significant improvement and nonsignificant improvement on days 3 and 5, respectively. ( ): it represents percentage per group.
